Loading resource…

Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA; Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of
The document provides a comprehensive overview of acute myeloid leukaemia, detailing recent updates in classification by WHO and the International Consensus Classification. It emphasizes the evolution of treatment options, including targeted therapies and the integration of measurable residual disease into risk assessments. The authors discuss the implications of these advancements for patient outcomes and the importance of timely diagnosis and management.
No account needed